share_log

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharmaceuticals | 8-K:Shuttle Pharma收到納斯達克不遵守上市規則5250 (c) (1)通知
美股SEC公告 ·  08/26 16:12
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息